Mednow Investor Presentation Deck

1. Financials Virtual Pharmacy Growth: Strong base developed in the "build phase" and now ready for Large Partnership Launches Early Strong Revenue Growth ¹ $4.1M $500K 720% Growth $2M Jan 22 $1.8M Jan '23 Qtrly Growth (Annualized Revenue) ¹ $3M $3M Jan ¹21 Revenue includes virtual pharmacy revenue and Medvisit (excludes Infusicare and Livercare) 150% Growth $3.3M $3.7M $3.9M $4.5M Fiscal Q1 Fiscal Q2 Fiscal Q3 Fiscal Q4 Fiscal Q1 Fiscal Q2 Fiscal Q3 2022 2022 2022 2022 2023 2023 2023 21

View entire presentation